Sponsor:
University of Pennsylvania
Code:
NCT05658913
Conditions
Alzheimer's Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
AV-1451
Brief summary:
Conditions
Alzheimer's Disease
Study ID
NCT05658913
Start date
Mar 14, 2023
Status verified date
Sep, 2026
Completion date
Dec, 2029
Anticipated
Primary completion date
Dec, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Interventions
AV-1451
Primary outcome measure
Central contacts
Locations
Massachusetts General Hospital
Recruiting
Boston, Massachusetts, United States, 02114-2696
Contacts
Principal Investigator:
Bradford Dickerson, MD
University of Pennsylvania
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contacts
Principal Investigator:
David Wolk, MD
Sponsor
University of Pennsylvania
Last update posted
Sep 4, 2026
Last verified
Sep, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by University of Pennsylvania on 2026-09-04.